Koen B Pouwels1,2,3, F Christiaan K Dolk1,2, David R M Smith1, Julie V Robotham1, Timo Smieszek1,3. 1. Modelling and Economics Unit, National Infection Service, Public Health England, London, UK. 2. PharmacoTherapy, -Epidemiology & -Economics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands. 3. MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College School of Public Health, London, UK.
Abstract
Objectives: Previous work based on guidelines and expert opinion identified 'ideal' prescribing proportions-the overall proportion of consultations that should result in an antibiotic prescription-for common infectious conditions. Here, actual condition-specific prescribing proportions in primary care in England were compared with ideal prescribing proportions identified by experts. Methods: All recorded consultations for common infectious conditions (cough, bronchitis, exacerbations of asthma or chronic obstructive pulmonary disease, sore throat, rhinosinusitis, otitis media, lower respiratory tract infection, upper respiratory tract infection, influenza-like illness, urinary tract infection, impetigo, acne, gastroenteritis) for 2013-15 were extracted from The Health Improvement Network (THIN) database. The proportions of consultations resulting in an antibiotic prescription were established, concentrating on acute presentations in patients without relevant comorbidities. These actual prescribing proportions were then compared with previously established 'ideal' proportions by condition. Results: For most conditions, substantially higher proportions of consultations resulted in an antibiotic prescription than was deemed appropriate according to expert opinion. An antibiotic was prescribed in 41% of all acute cough consultations when experts advocated 10%. For other conditions the proportions were: bronchitis (actual 82% versus ideal 13%); sore throat (actual 59% versus ideal 13%); rhinosinusitis (actual 88% versus ideal 11%); and acute otitis media in 2- to 18-year-olds (actual 92% versus ideal 17%). Substantial variation between practices was found. Conclusions: This work has identified substantial overprescribing of antibiotics in English primary care, and highlights conditions where this is most pronounced, particularly in respiratory tract conditions.
Objectives: Previous work based on guidelines and expert opinion identified 'ideal' prescribing proportions-the overall proportion of consultations that should result in an antibiotic prescription-for common infectious conditions. Here, actual condition-specific prescribing proportions in primary care in England were compared with ideal prescribing proportions identified by experts. Methods: All recorded consultations for common infectious conditions (cough, bronchitis, exacerbations of asthma or chronic obstructive pulmonary disease, sore throat, rhinosinusitis, otitis media, lower respiratory tract infection, upper respiratory tract infection, influenza-like illness, urinary tract infection, impetigo, acne, gastroenteritis) for 2013-15 were extracted from The Health Improvement Network (THIN) database. The proportions of consultations resulting in an antibiotic prescription were established, concentrating on acute presentations in patients without relevant comorbidities. These actual prescribing proportions were then compared with previously established 'ideal' proportions by condition. Results: For most conditions, substantially higher proportions of consultations resulted in an antibiotic prescription than was deemed appropriate according to expert opinion. An antibiotic was prescribed in 41% of all acute cough consultations when experts advocated 10%. For other conditions the proportions were: bronchitis (actual 82% versus ideal 13%); sore throat (actual 59% versus ideal 13%); rhinosinusitis (actual 88% versus ideal 11%); and acute otitis media in 2- to 18-year-olds (actual 92% versus ideal 17%). Substantial variation between practices was found. Conclusions: This work has identified substantial overprescribing of antibiotics in English primary care, and highlights conditions where this is most pronounced, particularly in respiratory tract conditions.
Authors: Roderick P Venekamp; Sharon L Sanders; Paul P Glasziou; Chris B Del Mar; Maroeska M Rovers Journal: Cochrane Database Syst Rev Date: 2015-06-23
Authors: Katherine E Fleming-Dutra; Adam L Hersh; Daniel J Shapiro; Monina Bartoces; Eva A Enns; Thomas M File; Jonathan A Finkelstein; Jeffrey S Gerber; David Y Hyun; Jeffrey A Linder; Ruth Lynfield; David J Margolis; Larissa S May; Daniel Merenstein; Joshua P Metlay; Jason G Newland; Jay F Piccirillo; Rebecca M Roberts; Guillermo V Sanchez; Katie J Suda; Ann Thomas; Teri Moser Woo; Rachel M Zetts; Lauri A Hicks Journal: JAMA Date: 2016-05-03 Impact factor: 56.272
Authors: Martin C Gulliford; Alex Dregan; Michael V Moore; Mark Ashworth; Tjeerd van Staa; Gerard McCann; Judith Charlton; Lucy Yardley; Paul Little; Lisa McDermott Journal: BMJ Open Date: 2014-10-27 Impact factor: 2.692
Authors: Mia Tyrstrup; Alike van der Velden; Sven Engstrom; Geert Goderis; Sigvard Molstad; Theo Verheij; Samuel Coenen; Niels Adriaenssens Journal: Scand J Prim Health Care Date: 2017-03-03 Impact factor: 2.581
Authors: Rachael Boggon; Richard Hubbard; Liam Smeeth; Martin Gulliford; Jackie Cassell; Susan Eaton; Munir Pirmohamed; Tjeerd-Pieter van Staa Journal: BMC Pulm Med Date: 2013-05-31 Impact factor: 3.317
Authors: Ellen Berni; Laura A Scott; Sara Jenkins-Jones; Hanka De Voogd; Monica S Rocha; Chris C Butler; Christopher Ll Morgan; Craig J Currie Journal: Antibiotics (Basel) Date: 2016-07-04
Authors: Timo Smieszek; Koen B Pouwels; F Christiaan K Dolk; David R M Smith; Susan Hopkins; Mike Sharland; Alastair D Hay; Michael V Moore; Julie V Robotham Journal: J Antimicrob Chemother Date: 2018-02-01 Impact factor: 5.790
Authors: Kevin L Schwartz; Bradley J Langford; Nick Daneman; Branson Chen; Kevin A Brown; Warren McIsaac; Karen Tu; Elisa Candido; Jennie Johnstone; Valerie Leung; Jeremiah Hwee; Michael Silverman; Julie H C Wu; Gary Garber Journal: CMAJ Open Date: 2020-05-07
Authors: David R M Smith; F Christiaan K Dolk; Koen B Pouwels; Morag Christie; Julie V Robotham; Timo Smieszek Journal: J Antimicrob Chemother Date: 2018-02-01 Impact factor: 5.790
Authors: Jay-Hyun Jo; Catriona P Harkins; Nicole H Schwardt; Jessica A Portillo; Matthew D Zimmerman; Claire L Carter; Md Amir Hossen; Cody J Peer; Eric C Polley; Véronique Dartois; William D Figg; Niki M Moutsopoulos; Julia A Segre; Heidi H Kong Journal: Sci Transl Med Date: 2021-12-22 Impact factor: 17.956
Authors: Andrew Oliver; Zhengyao Xue; Yirui T Villanueva; Blythe Durbin-Johnson; Zeynep Alkan; Diana H Taft; Jinxin Liu; Ian Korf; Kevin D Laugero; Charles B Stephensen; David A Mills; Mary E Kable; Danielle G Lemay Journal: mBio Date: 2022-05-10 Impact factor: 7.786
Authors: Guneet K Jasuja; Ryann L Engle; Avy Skolnik; Adam J Rose; Alexandra Male; Joel I Reisman; Barbara G Bokhour Journal: J Gen Intern Med Date: 2019-09-11 Impact factor: 6.473